Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month ‘proof-of-concept’ study

Aim: Stepwise intensification of insulin treatment to match the progressive decline of endogenous insulin secretion has been shown to be an effective management strategy in type 2 diabetes mellitus (T2DM). The efficacy of initiating and titrating a single bolus dose of insulin glulisine to baseline insulin glargine plus oral hypoglycaemic agents (OHAs) was investigated.

[1]  V. Basevi.  Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.

[2]  A. Farmer,et al.  Three-year efficacy of complex insulin regimens in type 2 diabetes. , 2009, The New England journal of medicine.

[3]  D. Owens,et al.  Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept , 2009, Diabetes/metabolism research and reviews.

[4]  D. Nathan.  Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2009, Diabetes Care.

[5]  W. A. Scherbaum,et al.  Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single‐dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs , 2008, Diabetes, obesity & metabolism.

[6]  D. Owens,et al.  Type 2 diabetes: a well-characterised but suboptimally controlled disease. Can we bridge the divide? , 2008, Diabetes & metabolism.

[7]  A. Farmer,et al.  Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. , 2007, The New England journal of medicine.

[8]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[9]  G Hu,et al.  Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study , 2004, Diabetologia.

[10]  G. Nichols,et al.  The burden of treatment failure in type 2 diabetes. , 2004, Diabetes care.

[11]  J. Rosenstock,et al.  The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. , 2003, Diabetes care.

[12]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[13]  A. Winship.  Interest. , 1893 .

[14]  S. Schinner.  Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .

[15]  D. Power.  Standards of medical care in diabetes. , 2006, Diabetes care.